The first Symbicort generic, simply referred to as budesonide/formoterol inhaler, was approved by the Food and Drug Administration (FDA) in February 2020 and is roughly half the cost of Symbicort.

The first generic version of Symbicort -- a metered-dose inhaler that combines the corticosteroid budesonide with the long-acting bronchodilator formoterol -- has been approved for asthma and ...

Rhinocort Hayfever & Allergy Extra Strength Nasal Spray contains 64 micrograms of budesonide as the active ingredient per spray, and the following inactive ingredients: ...

CyDex Pharmaceuticals announced the presentation of Phase 2 clinical trial results of its Captisol-Enabled budesonide/azelastine nasal spray (CDX-313) for seasonal allergic rhinitis (SAR).

Objective: To evaluate the efficacy and tolerability of two inhaled corticosteroid treatment regimens, fluticasone propionate (FP) delivered from a Diskus TM inhaler and budesonide delivered from ...